iBio Inc. Shares Fall 1.5% Below Previous 52-Week Low - Market Mover
The shares fell 1.5% lower than its previous 52-week low of $0.50, with trading volume lower than its 30 day average
Jan 14, 2022 by Kwhen Finance Editors
iBio Inc. (IBIO) shares closed 1.5% lower than its previous 52 week low, giving the company a market cap of $108M. The stock is currently down 8.9% year-to-date, down 68.4% over the past 12 months, and down 87.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%.
Trading Activity
- Trading volume this week was 35.3% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| iBio Inc. | -1.5 | -8.9 | -68.4 | -82.0 | 2.0 |
| Dow Jones Industrial Average | -0.5 | -0.1 | 18.8 | -1.4 | 24.0 |
| S&P 500 Index | -1.4 | -0.8 | 26.0 | -1.6 | 29.9 |
| Health Care | -1.8 | -3.8 | 15.2 | -4.5 | 22.7 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 424.2%
- The company's stock price performance over the past 12 months lags the peer average by 102.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| iBio Inc. | IBIO | 0 | -8.9 | -68.4 | -82.0 | 2.0 |
| Peer Avg | N/A | 8.0 | -1.7 | -33.8 | -48.5 | 27.7 |
| Johnson & Johnson | JNJ | 25.0 | -0.7 | 10.1 | -4.9 | 13.7 |
| Emergent Biosolutions Inc | EBS | 11.5 | 11.7 | -53.0 | -61.6 | 63.3 |
| Nektar Therapeutics | NKTR | -4.6 | -9.1 | -35.5 | -54.0 | 16.1 |
| Genocea Biosciences Inc | GNCA | 0 | -8.6 | -56.7 | -73.6 | 17.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: